Research Article

Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis

Table 2

UPIIIa level in plasma and urine in BC and control group C.

GroupUPIIIa in urine [ng/mg cr.]UPIIIa in plasma [ng/ml]p-value
MeanSDMeMeanSDMein urinein plasma

C1.020.540.980.580.310.65p≤0.001p≤0.001
BC2.441.412.111.470.761.32BC vs CBC vs C

NMIBC2.381.362.101.370.561.25p=0.5978p=0.4312
MIBC2.641.592.231.771.151.32NMIBC vs MIBCNMIBC vs MIBC

LG2.441.372.111.420.621.32p≤0.001 p≤0.001
LG vs CLG vs C
HGp=0≤0.001 p≤0.001
2.441.482.211.520.901.22HG vs CHG vs C
p=0.9945p=0.9939
LG vs HGLG vs HG

Non-smoking BC2.021.112.020.960.610.96p> 0.05p> 0.05
Smoking BC2.111.482.111.320.811.32non-smoking BCnon-smoking BC
vs smoking BCvs smoking BC

Non-smoking C1.280.411.170.680.330.69p>0.05p>0.05
Smoking C0.940.560.910.5530.300.65non-smoking Cnon-smoking C
vs smoking Cvs smoking C

UPIIIa: uroplakin IIIa; C: control group; BC: patient group; NMIBC: nonmuscle invasive BC; MIBC: muscle invasive BC; LG: low grade; HG: high grade; SD: standard deviation; p: statistically significant difference; Me: median